Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Notice of EGM

28th Oct 2008 16:41

RNS Number : 8769G
Assura Group Limited
28 October 2008
 



For Immediate release

28 October 2008

Assura Group Limited ('Assura' or the 'Company')

Posting of Prospectus and Notice of Extraordinary General Meeting

Notification of date of Announcement of Interim Results

Assura Group Limited (LSE: AGR), the UK healthcare company which partners with GPs, consultants and other healthcare professionals to deliver high quality patient care, pharmacy and innovative property solutions in primary care, announces that it has today posted to shareholders a prospectus relating to its proposed placing of up to 81,081,080 new Ordinary Shares as announced on 7 October 2008 together with the notice of the Extraordinary General Meeting to be held on 17 November 2008.

If the proposals are approved at the Extraordinary General Meeting, it is expected that the new Ordinary Shares will be admitted to trading on The London Stock Exchange on 18 November 2008.

Copies of the above document have been submitted to the UK Listing Authority and will shortly be available for inspection at the UK Listing Authority's Document Viewing Facility, which is situated at:

Financial Services Authority

25 The North Colonnade

Canary Wharf

London

E14 5HS

Assura Group Limited also announces that it will announce its Interim Results for the six month period ended on 30 September 2008 on 26 November 2008.

Ends

Enquiries:

Assura Group

 +44 (0) 207 107 3800

Louise Bathersby/Greg McMahon

Financial Dynamics 

+44 (0)20 7831 3113

Ben Atwell/Emma Thompson

Disclaimer - Intended Addressees 

Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein. Your right to access the UKLA's Document Viewing Facility is conditional upon complying with the above requirement.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NOEEAKEPADXPFFE

Related Shares:

Assura
FTSE 100 Latest
Value8,809.74
Change53.53